Analysis of xenobiotic detoxification system mediated by efflux transporters

Yakugaku Zasshi

Volumn 119, Issue 11, 1999, Pages 822-834

  Suzuki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

ABC transporter; Biliary excretion; Blood brain barrier; Intestinal excretion; MRP

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 6 HYDROXY 5,7 DIMETHYL 2 METHYLAMINO 4 (3 PYRIDYLMETHYL)BENZOTHIAZOLE; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; ABC TRANSPORTER; AMPICILLIN; CARRIER PROTEIN; CEFODIZIME; CEFTRIAXONE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ESTRADIOL; GLUTATHIONE; GLYCOPROTEIN P; GLYCYRRHIZIC ACID; GREPAFLOXACIN; IRINOTECAN; LIOTHYRONINE; LIQUIRITIGENIN; PRAVASTATIN; TEMOCAPRILAT; TETRAHYDROFOLIC ACID; XENOBIOTIC AGENT;

BILIARY EXCRETION; BLOOD BRAIN BARRIER; CELL MEMBRANE TRANSPORT; CHOROID PLEXUS; DRUG CONJUGATION; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; HUMAN; NONHUMAN; REVIEW; SMALL INTESTINE MUCOSA; TRANSPORT KINETICS; XENOBIOTIC METABOLISM;

EID: 0032701151     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi1947.119.11_822     Document Type: Review

References (45)

1. Kusuhara H., Suzuki H., Sugiyama Y., J. Pharm. Sci., 87, 1025-1040 (1998).
2. Suzuki H., Sugiyama Y., Semin. Liv. Dis., 18, 359-376 (1998).
3. Suzuki H., Sugiyama Y., "Membrane transporters as drug targets," ed. Amidon G., Sadee W., Plenum Publishing Corp., New York, 1999, pp. 387-440.
4. Suzuki H., Terasaki T., Sugiyama Y., Adv. Drug Deliv. Rev., 25, 257-285 (1997).
5. Kobayashi K., Sogame Y., Hara H., Hayashi K., J. Biol. Chem., 265, 7737-7741 (1990).
6. Ishikawa T., Müller M., Klunemann C., Schaub T., Keppler D., J. Biol. Chem., 265, 19279-19286 (1990).
7. Ishizuka H., Konno K., Shiina T., Naganuma H., Nishimura N., Ito K., Suzuki H., Sugiyama Y., J. Pharmacol. Exp. Ther., 290, 1324-1330 (1999).
8. Cole S. P., Bhardwaj G., Gerlach J. H., Mackie J. E., Grant C. E., Almquist K. C., Stewart A. J., Kurz E. U., Duncan A. M., Deeley R. G., Science, 258, 1650-1654 (1992).
9. Deeley R. G., Cole S. P., Semin. Cancer Biol., 8, 193-204 (1997).
10. Paulusma C. C., Bosma P. J., Zaman G. J., Bakker C. T., Otter M., Scheffer G. L., Scheper R. J., Borst P., Oude Elferink R. P., Science, 271, 1126-1128 (1996).
11. Büchler M., König J., Brom M., Kartenbeck J., Spring H., Horie T., Keppler D., J. Biol. Chem. 271, 15091-15098 (1996).
12. Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y., Int. Hepatol. Commun., 4, 292-299 (1996).
13. Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y., Am. J. Physiol., 272, G16-G22 (1997).
14. Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y., J. Biol. Chem., 273, 1684-1688 (1998).
15. Kinoshita S., Suzuki H., Ito K., Kume K., Shimizu T., Sugiyama Y., Pharm. Res., 15, 1851-1856 (1998).
16. Evers R., Kool M., van Deemter L., Janssen H., Calafat J., Oomen L. C., Paulusma C. C., Oude Elferink R. P., Baas F., Schinkel A. H., Borst P., J. Clin. Invest 101, 1310-1319 (1998).
17. Hirohashi T., Suzuki H., Ito K., Kume K., Shimizu T., Sugiyama Y., Mol. Pharmacol., 53, 1068-1075 (1998).
18. Kiuchi Y., Suzuki H., Hirohashi T., Tyson C. A., Sugiyama Y., FEBS Letters, 433, 149-152 (1998).
19. Takada T., Suzuki H., Ogawa K., Ito K., Hirohashi T., Sugiyama Y., Hepatol., in press (Abstract submitted to 50th AASLD annual meeting, November 5-9, 1999, Dallas).
20. Hirohashi T., Suzuki H., Sugiyama Y., J. Biol. Chem., 274, 15181-15185 (1999).
21. Kool M., van der Linden M., de Haas M., Scheffer G. L., de Vree J. M. L., Smith A. J., Jansen G., Peters G. J., Ponne N., Sheper R. J., Oude Elferink R. P. J., Baas F., Borst P., Proc. Natl. Acad. Sci. U.S.A., 96, 6914-6919 (1999).
22. König J., Rost D., Cui Y., Keppler D., Hepatol, 29, 1156-1163 (1999).
23. Schinkel A. H., Semin Cancer Biol., 8, 161-170 (1997).
24. Matsushita H., Suzuki H., Sugiyama Y., Sawada Y., Iga T., Kawaguchi Y., Hanano M., J. Pharmacol. Exp. Ther., 259, 620-625 (1991).
25. Leininger B., Ghersi-Egea J. F., Siest G., Minn A., J. Neurochem., 56, 1163-1168 (1991).
26. Homma M., Suzuki H., Kusuhara H., Naito M., Tsuruo T., Sugiyama Y., J. Pharmacol. Exp. Ther., 288, 198-203 (1999).
27. Tatsuta T., Naito M., Oh-hara T., Sugawara I., Tsuruo T., J. Biol. Chem., 267, 20383-20391 (1992).
28. Kusuhara H., Suzuki H., Naito M., Tsuruo T., Sugiyama Y., J. Pharmacol. Exp. Ther., 285, 1260-1265 (1998).
29. Regina A., Koman A., Piciotti M., Hafny B. E. I., Center M. S., J. Neurochem., 71, 705-715 (1998).
30. Suzuki H., Homma M., Sugiyama Y., Abstract Form of 2nd FEBS Advanced Lecture Course, "ATP-binding Cassette Transporters: From Multidrug Resistance to Genetic Disease," Feb. 21-26, 1999, Gosau, Austria, p. 96.
31. Ogawa M., Suzuki H., Sawada Y., Hanano M., Sugiyama Y., Am. J. Physiol., 266, R392-R399 (1994).
32. Suzuki H., Sawada Y., Sugiyama Y., Iga T., Hanano M., J. Pharmacol. Exp. Ther., 243, 1147-1152 (1987).
33. Angeletti R. H., Novikoff P. M., Juvvadi S. R., Fritschy J. M., Meier P. J., Wolkoff A. W., Proc. Natl. Acad. Sci. U.S.A., 94, 283-286 (1997).
34. Li L., Lee T. K., Meier P. J., Ballatori N., J. Biol. Chem., 273, 16184-16191 (1998).
35. Nishino J., Suzuki H., Sugiyama D., Kitazawa T., Ito K., Sugiyama Y., J. Pharmacol. Exp. Ther., 290, 289-294 (1999).
36. Ghersi-Egea J. F., Leninger-Muller B., Suleman G., Siest G., Minn A., J. Neurochem., 62, 1089-1096 (1994).
37. Ueda K., Suzuki H., Akiyama S., Sugiyama Y., Jpn. J. Cancer Res., 90, 439-447 (1999).
38. Fujii R., Mutoh M., Sumizawa T., Chen Z. S., Yoshimura A., Akiyama S., J. Natl. Cancer Inst., 86, 1781-1784 (1994).
39. Ishikawa T., Ali-Osman F., J. Biol. Chem., 268, 20116-20125 (1993).
40. Chu X.-Y., Suzuki H., Ueda K., Kato Y., Akiyama S., Sugiyama Y., J. Pharmacol. Exp. Ther., 288, 735-741 (1999).
41. Ito K., Suzuki H., Ueda K., Chu X.-Y., Akiyama S., Sugiyama Y., Abstract form of 2nd FEBS Advanced Lecture Course, "ATP-binding cassette Transporters: From Multidrug Resistance to Genetic Disease," Feb. 21-26, 1999, Gosau, Austria, p. 89.
42. Gotoh Y., Kato Y., Kinoshita S., Hirohashi T., Suzuki H., Sugiyama Y., Abstract form of Int'l Symposium, "Strategies for Optimizing Oral Drug Delivery: Scientific to Regulatory Approaches," April 19-21, 1999, Kobe, p. 122.